With 19.3 million new cases identified and 10 million cancer deaths reported in 2020, these diseases call for continued development and improvement of patient treatments, especially for malignancies that lack diagnostic and treatment options, like cholecystokinin receptor (CCK2R)-positive cancers. A promising and arising tool that has proven to be particularly effec...